CVC raises €350m through pioneering non-recourse Evonik exchangeable
In what is thought to be the first non-recourse exchangeable bond for a private equity firm, a CVC fund on Tuesday raised €350m through a highly-structured bond exchangeable into shares in German chemicals firm Evonik.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts